NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP)

CUSIP: 629444209

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
23,771,791
Total 13F shares
2,260,524
Share change
+1,211,882
Total reported value
$4,602,262
Put/Call ratio
0%
Price per share
$2.05
Number of holders
22
Value change
+$2,464,504
Number of buys
10
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 629444209?
CUSIP 629444209 identifies NRXP - NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP) as of Q1 2025

As of 31 Mar 2025, NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,260,524 shares. The largest 10 holders included Anson Funds Management LP, VANGUARD GROUP INC, AdvisorShares Investments LLC, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, STATE STREET CORP, TWO SIGMA INVESTMENTS, LP, BlackRock, Inc., NORTHERN TRUST CORP, and TOWNSQUARE CAPITAL LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.